These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites. Leysen JE; Gommeren W J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046 [TBL] [Abstract][Full Text] [Related]
6. Regulation by cations of [3H]spiroperidol binding associated with dopamine receptors of rat brain. Usdin TB; Creese I; Snyder SH J Neurochem; 1980 Mar; 34(3):669-76. PubMed ID: 6766497 [No Abstract] [Full Text] [Related]
7. Early supersensitive changes in [3H] spiroperidol binding in the isolated striatum. Csernansky JG; Friedhoff AJ; Bonnet KA Biochem Biophys Res Commun; 1982 Mar; 105(1):117-20. PubMed ID: 6124243 [No Abstract] [Full Text] [Related]
8. 3H-Spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated metabolites. Coupet J; Rauh CE Eur J Pharmacol; 1979 Apr; 55(2):215-8. PubMed ID: 456420 [TBL] [Abstract][Full Text] [Related]
9. Solubilization and characterization of [3H]spiroperidol binding sites from subcellular fractions of the calf striatum. Clement-Cormier YC; Kendrick PE Biochem Pharmacol; 1980 Mar; 29(6):897-903. PubMed ID: 7387707 [No Abstract] [Full Text] [Related]
10. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum. Waddington JL; Cross AJ; Longden A; Owen F; Poulter M Eur J Pharmacol; 1979 Oct; 58(3):341-2. PubMed ID: 510367 [No Abstract] [Full Text] [Related]
11. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol. Hancock AA; Marsh CL Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230 [TBL] [Abstract][Full Text] [Related]
12. Two binding sites for 3H-spiroperidol on rat striatal membranes. Briley M; Langer SZ Eur J Pharmacol; 1978 Aug; 50(3):283-4. PubMed ID: 28956 [No Abstract] [Full Text] [Related]
13. A comparative study of [3H]haloperidol and [3H]spiroperidol binding to receptors on rat cerebral membranes. Howlett DR; Nahorski SR FEBS Lett; 1978 Mar; 87(1):152-6. PubMed ID: 631328 [No Abstract] [Full Text] [Related]
14. [3H]Haloperidol and [3H]spiroperidol binding in rat striatum during ageing. Govoni S; Spano PF; Trabucchi M J Pharm Pharmacol; 1978 Jul; 30(7):448-9. PubMed ID: 27613 [No Abstract] [Full Text] [Related]
15. Evidence for loss of brain [3H]spiroperidil and [3H]ADTN binding sites in rabbit brain with aging. Thal LJ; Horowitz SG; Dvorkin B; Makman MH Brain Res; 1980 Jun; 192(1):185-94. PubMed ID: 7378779 [TBL] [Abstract][Full Text] [Related]
16. Effect of cyclo(leucyl-glycine) on [3H]spiroperidol binding in the corpus striatum and hypothalamus of spontaneously hypertensive rats. Bhargava HN Eur J Pharmacol; 1984 Apr; 100(1):109-12. PubMed ID: 6723774 [TBL] [Abstract][Full Text] [Related]
17. Dopaminergic component of [3H]spiroperidol binding in the rat anterior cerebral cortex. Marchais D; Tassin JP; Bockaert J Brain Res; 1980 Feb; 183(1):235-40. PubMed ID: 7357406 [No Abstract] [Full Text] [Related]
18. Inhibition of [3H]spiroperidol binding by in vitro addition of ethanol. Hruska RE; Silbergeld EK J Neurochem; 1980 Sep; 35(3):750-2. PubMed ID: 7452286 [TBL] [Abstract][Full Text] [Related]
19. Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors. Tachizawa H; Sudo K; Sano M Eur J Pharmacol; 1979 Nov; 59(3-4):245-51. PubMed ID: 43256 [TBL] [Abstract][Full Text] [Related]
20. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390. O'Boyle KM; Waddington JL Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]